Compare PTCT & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | GTES |
|---|---|---|
| Founded | 1998 | 1911 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 6.6B |
| IPO Year | 2006 | 2017 |
| Metric | PTCT | GTES |
|---|---|---|
| Price | $72.08 | $24.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 9 |
| Target Price | ★ $80.65 | $28.56 |
| AVG Volume (30 Days) | 1.4M | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | 29.73 |
| EPS | N/A | ★ 0.23 |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $5.83 |
| Revenue Next Year | $17.70 | $3.95 |
| P/E Ratio | ★ N/A | $111.85 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $20.39 |
| 52 Week High | $87.50 | $28.47 |
| Indicator | PTCT | GTES |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 45.05 |
| Support Level | $61.59 | $23.99 |
| Resistance Level | $79.67 | $26.29 |
| Average True Range (ATR) | 3.55 | 0.88 |
| MACD | 0.59 | -0.09 |
| Stochastic Oscillator | 49.85 | 19.65 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.